Profits Double Up At Invitrogen

by The Editors on April 29, 2008

InvitrogenlogoOur favorite life sciences company, Carlsbad’s Invitrogen, just announced that its first quarter profits have doubled since the first quarter of 2007. Looks like CEO Greg Lucier is worth every penny of his package.

Analysts have attributed this encouraging bottom line to improved profit margins, share buybacks and lower taxes. So much so that the Carlsbad, California-based company did better than the $334.5m in revenue analysts had been predicting. . . . Looking ahead to full-year 2008, the company said that revenue growth was expected, ‘in percentage terms to be in the high single digits.’ This is up from a previous forecast for mid-single-digit growth.

If we knew anything about the stock market we’d probably give Invitrogen a strong buy rating.

[Link: Lab Technologist]

{ 0 comments… add one now }

Leave a Comment

Previous post:

Next post: